Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 2.22 % |
3 Month Return | -8.93 % |
1 Year Return | -14.15 % |
Market Stats | |
Previous Close | ₹57.52 |
Open | ₹58.64 |
Volume | 685.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹55.57Cr |
P/E Ratio | 19.5 |
PEG Ratio | 13 |
Market Cap | ₹55.57 Cr |
P/B Ratio | 1.37 |
EPS | 1.51 |
Dividend Yield | 1.39 |
Sector | Pharmaceuticals |
ROE | 3.66 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹55.57 Cr | 43.91% | 0.50 | ₹1 Cr | ₹67 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Sandu Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 15.91 Cr → 17.73 Cr (in ₹), with an average increase of 5.3% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 0.17 Cr → 0.5 Cr (in ₹), with an average increase of 66.0% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 72.7%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 57.09% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.90% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 103.9%
Price Dip
In the last 1 year, Sandu Pharma. stock has moved down by -14.2%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 42.9% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 57.09% | 0.00 | |
Others | 0.01% | 0.00 |
Sandu Pharmaceuticals Ltd in the last 5 years
Lowest (18.52x)
October 29, 2024
Today (19.50x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (66.08x)
February 19, 2024
Sandu Pharmaceuticals Ltd’s net profit fell -9.09% since last year same period to ₹0.50Cr in the Q2 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 194.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2024, Sandu Pharmaceuticals Ltd has declared dividend of ₹0.80 - translating a dividend yield of 2.72%.
Read More about DividendsBearish
Neutral
Bullish
Sandu Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Sandu Pharmaceuticals Ltd (524703) share price today is ₹57
Sandu Pharmaceuticals Ltd is not listed on NSE
Sandu Pharmaceuticals Ltd is listed on BSE
PE Ratio of Sandu Pharmaceuticals Ltd is 19.5
PE ratio = Sandu Pharmaceuticals Ltd Market price per share / Sandu Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Sandu Pharmaceuticals Ltd(524703) is 685.00.
Today’s market capitalisation of Sandu Pharmaceuticals Ltd(524703) is ₹55.57Cr.
Sandu Pharmaceuticals Ltd(524703 | Price |
---|---|
52 Week High | ₹85 |
52 Week Low | ₹54 |
Sandu Pharmaceuticals Ltd(524703) share price is ₹57. It is down -32.94% from its 52 Week High price of ₹85
Sandu Pharmaceuticals Ltd(524703) share price is ₹57. It is up 5.56% from its 52 Week Low price of ₹54
Sandu Pharmaceuticals Ltd(524703 | Returns |
---|---|
1 Day Returns | -0.52% |
1 Month Returns | 2.22% |
3 Month Returns | -8.93% |
1 Year Returns | -14.15% |